NC Cannabis Advisory Council Recommends Adult-Use Cannabis Program
The North Carolina adult-use cannabis program interim report highlights key policy shifts affecting patient safety and product standardization. This development is crucial for clinicians and patients navigating cannabis access. Understanding the…
Dan Patrick Adds Data Centers, Prediction Markets, and THC to Senate Priorities
Texas medical cannabis patient access is a key focus as legislative priorities evolve. Changes in THC policy directly affect treatment pathways for qualifying patients. Monitoring these developments is crucial for clinicians and patients alike.
State of Texas: Smokable Hemp Ban Takes Effect, Businesses Adapt
The 2026 Texas hemp ban marks a significant change in access to smokable hemp products. This ban affects patients relying on inhaled CBD for rapid relief. Businesses and patients are adapting to new regulations and alternative delivery methods.
Bloomington’s Alternative Care Solutions Earns Community Award
Community acceptance medical cannabis is a key factor in reducing stigma and improving patient access. Bloomington's Alternative Care Solutions recently won a community award recognizing this progress. This reflects growing integration of medical…
Hemp Businesses in Massachusetts Face Uncertain Future Amid Federal Ban
Federal hemp regulatory uncertainty is creating challenges for Massachusetts hemp businesses and patient access to cannabinoid therapies. The looming federal ban on intoxicating hemp compounds complicates clinical prescribing and treatment continuity.…
It’s Legal in Michigan, But Activists Say Hash Bash Is Still a Protest
Cannabis activism and policy advocacy continue to shape Michigan's regulatory landscape in 2026. Despite legalization, activists highlight ongoing challenges with taxation and patient access. Understanding cannabis activism and policy advocacy is crucial…
EBCI Tribal Council Suspends Qualla Enterprises Board Amid Cannabis Investigation
Tribal cannabis governance disruptions can significantly impact patient access and regulatory compliance. The EBCI Tribal Council's suspension of the Qualla Enterprises board highlights these challenges. Patients relying on tribal cannabis operations…
FBI Clarifies Hemp Investment and Employment Policy for Agents
The FBI hemp policy clarification confirms agents can invest in and work for hemp companies but not marijuana businesses. This distinction reflects the federal legal framework impacting patient access to cannabis medicines. Understanding this policy…
US: Critical Updates for Cannabis Taxpayers as the 2025 Filing Deadline Approaches
Cannabis tax compliance challenges are increasingly significant as the 2025 filing deadline approaches. These challenges impact cannabis business operations and patient access to medical cannabis. Understanding these tax issues is critical for both…
Will Hemp Products Be Banned in 2026? Kentucky Brand Introduces New THC Drinks
The hemp-derived intoxicating products ban 2026 raises significant regulatory uncertainty affecting patient access and product safety. Kentucky's new THC drinks highlight challenges in legal status and dosing consistency. Clinicians must understand these…
